By Todd Hobbs, MD, Chief Medical Officer, Novo Nordisk Inc. | Published November 29 2018
For more than half of the 30 years I’ve lived with type 1 diabetes, I depended on human insulin to effectively control my blood sugars.
During that time, the U.S healthcare system has changed a lot, and we know that this is causing people to pay more for their healthcare and their medicines, including the medicines we make here at Novo Nordisk. Several healthcare cost solutions are being discussed in the news. If insulin prices matter to you, then you’re likely following to see how some of these changes play out.
We have also seen some misinformation about human insulin that I want to comment on. Specifically, I want to share why these older insulins can be an available, effective, and affordable option for people who require insulin for their diabetes care and do not have access to the modern insulin analogs. There’s been a lot of talk online saying the opposite and, as a doctor and the chief medical officer of Novo Nordisk, I don’t want someone who could benefit from human insulin not to use it because they’ve been misinformed that it’s not safe. Here are some important facts to know.
As someone living well with type 1 diabetes, if I had to take human insulin again, I most certainly would. And as a doctor, I hope this helped you feel more informed on the truth about human insulin. Don’t forget to talk to your healthcare provider to determine what options are right for your treatment.
We use Facebook as our commenting platform. By entering your comment above you acknowledge that the information you post will not only be subject to Novo Nordisk community guidelines but will be posted on Facebook in accordance with their Terms of Service and Data Policy and subject to their Community Standards.